Literature DB >> 9661614

Secondary hyperparathyroidism in a patient with eight parathyroid glands.

O J Hines1, H E Gordon.   

Abstract

The etiology of secondary hyperparathyroidism is multifactorial, and as many as 10% of patients will ultimately require surgical intervention. This condition is most commonly caused by four-gland hyperplasia. We describe a patient who presented with secondary hyperparathyroidism and symptoms of memory loss, pruritus, constipation, and bone and joint pain. These complaints could not be controlled with conventional therapy. Over a three-year period, the patient underwent three neck explorations, with complete and persistent relief of his symptoms following the last parathyroidectomy. A total of eight parathyroid glands were removed during these three procedures. Although recurrence of hyperparathyroidism can be caused by seeding at the time of operation, the glands removed during the second and third procedures were not the typical miliary seeding seen with this complication. These glands were solid and hypertrophied and were found in areas not previously explored. A discussion of the possible causes of this unusual presentation is included.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661614     DOI: 10.1210/jcem.83.7.4904

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Eight parathyroid glands incidentally discovered during a surgical intervention for secondary hyperparathyroidism: an unusual clinical finding.

Authors:  G Amato; E Lalli; G Mazziotti; G De Felice; M Rotondi; G Vitolo; A Saggese; A Livrea; A Bellastella; C Carella
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  Unusual recurrent renal secondary hyperparathyroidism caused by hyperplastic autograft with supernumerary parathyroid adenoma: A case report.

Authors:  Jun Zhang; Meng-Jie Dong; Jun Yang; Dan Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.